Annual Drug Patent Expirations for NOURIANZ Nourianz is a drug marketed by Kyowa Kirin and is included in one NDA. It is available from one supplier. There are four patents…
The post New patent expiration for Kyowa Kirin drug NOURIANZ appeared first on…
New patent expiration for Kyowa Kirin drug NOURIANZ Read Post »
This chart shows the drugs with the most supplementary protection certificates (SPCs). SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating for the long…
The post Which drugs have the most supplementa…
Which drugs have the most supplementary protection certificates? Read Post »
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There are nine patents…
The post New patent for Janssen Biotech drug ERLEADA appeared first on DrugP…
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Azurity drug NYMALIZE appeared first on DrugPa…
JANUMET XR (metformin hydrochloride; sitagliptin phosphate) Merck sharp dohme Patent: 6,699,871 Expiration: Jan 26, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of January 22, 2023 Read Post »
Annual Drug Patent Expirations for BREXAFEMME Brexafemme is a drug marketed by Scynexis and is included in one NDA. It is available from one supplier. There are four patents protecting…
The post New patent for Scynexis drug BREXAFEMME appeared first on…
Annual Drug Patent Expirations for BRAFTOVI Braftovi is a drug marketed by Array Biopharma Inc and is included in one NDA. It is available from one supplier. There are thirteen…
The post New patent for Array Biopharma drug BRAFTOVI appeared first on Dr…
Annual Drug Patent Expirations for STEGLUJAN Steglujan is a drug marketed by Msd Sub Merck and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Msd Sub drug STEGLUJAN appeared first on DrugPa…
New patent expiration for Msd Sub drug STEGLUJAN Read Post »
Annual Drug Patent Expirations for JANUMET Janumet is a drug marketed by Merck Sharp Dohme and is included in two NDAs. It is available from two suppliers. There are four…
The post New patent expiration for Merck Sharp drug JANUMET appeared first on Dr…
New patent expiration for Merck Sharp drug JANUMET Read Post »
Annual Drug Patent Expirations for JANUVIA Januvia is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from three suppliers. There are three…
The post New patent expiration for Merck Sharp drug JANUVIA appeared first on …
New patent expiration for Merck Sharp drug JANUVIA Read Post »
Get new actionable insights and updates from BiotechBlog
